Competing with giants like Takeda and Moderna, the plucky biotech believes it has unlocked a future with an easy, yearly oral vaccine.
Creative Diagnostics also offers Nipah virus ELISA kits suitable for quantifying IgM antibody activity specific to the Nipah virus glycoprotein in the serum or plasma of vaccinated, immunized, and ...
Morning Overview on MSN
Scientists finally crack mystery of rare blood clots after COVID shots
Researchers have identified the molecular mechanism behind vaccine-induced immune thrombotic thrombocytopenia, or VITT, a ...
This letter to the editor presents an in-depth overview of the current state of Nipah virus (NiV) vaccine development, highlighting both scientific advancements and critical challenges that still ...
Announcing a new article publication for Zoonoses journal. Vaccinia virus (VACV) confers cross-protective immunity against variola virus, the causative agent of smallpox, and has therefore been ...
Since COVID was first reported in December 2019, there have been more than 775 million recorded infections and more than 7 million deaths from the disease. This makes COVID the seventh-deadliest ...
Immunization has long been a foundation of public health, and recent advances in vaccine science are taking it further. Next-generation vaccines are designed for greater precision and adaptability, ...
A new review tracks expanding chikungunya transmission, chronic sequelae, diagnostics, and prevention advances through 2025.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results